rogletimide has been researched along with Breast Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzdar, AU; Roseman, BJ; Singletary, SE | 1 |
| Bonneterre, J; Feutrie, ML | 1 |
| Dowsett, M; Jacobs, S; Jones, AL; Lønning, PE; MacNeill, FA; Powles, TJ | 1 |
| Griggs, LJ; Jarman, M; Lewis, IA; McCague, R; Poon, GK | 1 |
| Coombes, RC; Dowsett, M; Griggs, LJ; Haynes, BP; Jarman, M; Jones, A; Lønning, PE; Mehta, A; Powles, T; Stein, R | 1 |
| Coombes, RC; Dowsett, M; Haynes, B; Jarman, M; Jones, A; Lonning, P; MacNeill, F; Mehta, A; Newton, C; Powles, TJ | 1 |
| Dowsett, M; Lønning, PE; Powles, TJ | 1 |
| Dowsett, M | 1 |
4 review(s) available for rogletimide and Breast Neoplasms
| Article | Year |
|---|---|
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 1997 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles | 1999 |
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Fadrozole; Female; Humans; Imidazoles; Menopause; Nitriles | 1990 |
Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Estrogen Antagonists; Fadrozole; Humans; Imidazoles; Nitriles | 1990 |
1 trial(s) available for rogletimide and Breast Neoplasms
| Article | Year |
|---|---|
Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.
Topics: Aged; Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Biological Availability; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Female; Hormones; Humans; Menopause; Middle Aged | 1991 |
3 other study(ies) available for rogletimide and Breast Neoplasms
| Article | Year |
|---|---|
The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Estrogens; Female; Humans; Hydrocortisone; Middle Aged | 1992 |
Characterisation of metabolites of 3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione, a potential breast cancer drug.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Reference Standards | 1991 |
Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Middle Aged; Time Factors | 1991 |